Previous work have shown that legumain might be an important marker since it is universally overexpressed in metastatic gastric cancer patients (Dando et al., 1999; Barrett et al., 2001; Guo et al., 2013; Li et al., 2013; Zhang et al., 2016). The gene discussed is LGMN; the disease is gastric cancer.